Kaitlin Hurney
Optometrist · Greensburg, PANPI 1194139493
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 62.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $1,715 and has fallen 65.1% since, to $598 in 2025. Among optometrist clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $39.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$2K
- Johnson & Johnson Vision Care, Inc.$514
- Tarsus Pharmaceuticals, Inc.$395
- Bausch & Lomb Americas Inc.$165
- Oyster Point Pharma, Inc.$94
- Sun Pharmaceutical Industries Inc.$93
- plus $240 from 6 others
What the payments were for
- Consulting fees$1504%
- Speaking & faculty fees$1,47737%
- Food & beverage$2,32559%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$150
- XDEMVY$124
- Clariti Contact Lens$122
How this compares
$3,952 in reported general payments places this provider in the 90th percentile of 2,165 optometrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 17 | $12,713 |
| RestasisCyclosporine | 12 | $12,057 |
| Timolol Maleate | 19 | $74 |
| Latanoprost | 13 | $30 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Greensburg
- Chad GreenGreensburg$26K
- Erin KeimGreensburg$15K
- James DeomHazle Township$793K
- Gregory CaldwellDuncansville$547K
- Leslie O DellNew Freedom$388K
- Kevin BistlinePlymouth Meeting$302K
- Thomas KislanStroudsburg$266K
- Erick HendersonPittsburgh$266K
- Ryan YealyLancaster$164K
- Joseph SmayNew Kensington$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.